BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32429447)

  • 41. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
    Nakajima Y
    Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):172-88. PubMed ID: 9711036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylation of tumor-suppressor genes in neuroblastoma: The RASSF1A gene is almost always methylated in primary tumors.
    Michalowski MB; de Fraipont F; Plantaz D; Michelland S; Combaret V; Favrot MC
    Pediatr Blood Cancer; 2008 Jan; 50(1):29-32. PubMed ID: 17570703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disseminated neuroblastomas under 1 year of age: cell biology and prognosis.
    Lampert F; Christiansen H; Berner F; Terpe HJ; Berthold F
    J Neurooncol; 1997 Jan; 31(1-2):181-4. PubMed ID: 9049847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stage 4S Neuroblastoma: A Report of Two Cases Presenting with Extremes of Biological Behavior.
    Mubarak M; Singal AK; Gawdi A
    Gulf J Oncolog; 2019 May; 1(30):81-84. PubMed ID: 31242987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma.
    Yang H; Zheng W; Shuai X; Chang RM; Yu L; Fang F; Yang LY
    Oncotarget; 2015 Sep; 6(29):27736-50. PubMed ID: 26315541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rb knockdown accelerates bladder cancer progression through E2F3 activation.
    Wang JP; Jiao Y; Wang CY; Xu ZB; Zhang B
    Int J Oncol; 2017 Jan; 50(1):149-160. PubMed ID: 27922689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unique requirement for Rb/E2F3 in neuronal migration: evidence for cell cycle-independent functions.
    McClellan KA; Ruzhynsky VA; Douda DN; Vanderluit JL; Ferguson KL; Chen D; Bremner R; Park DS; Leone G; Slack RS
    Mol Cell Biol; 2007 Jul; 27(13):4825-43. PubMed ID: 17452454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A.
    Møller MB; Kania PW; Ino Y; Gerdes AM; Nielsen O; Louis DN; Skjødt K; Pedersen NT
    Leukemia; 2000 May; 14(5):898-904. PubMed ID: 10803523
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Upregulation of E2F transcription factor 3 is associated with poor prognosis in hepatocellular carcinoma.
    Zeng X; Yin F; Liu X; Xu J; Xu Y; Huang J; Nan Y; Qiu X
    Oncol Rep; 2014 Mar; 31(3):1139-46. PubMed ID: 24402082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful treatment of progressive stage 4s hepatic neuroblastoma in a neonate with intra-arterial chemoembolization.
    Weintraub M; Bloom AI; Gross E; Revel-Vilk S; Shahroor S; Koplewitz BZ; Freeman AI
    Pediatr Blood Cancer; 2004 Aug; 43(2):148-51. PubMed ID: 15236281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. E2F-1: a proliferative marker of breast neoplasia.
    Zhang SY; Liu SC; Al-Saleem LF; Holloran D; Babb J; Guo X; Klein-Szanto AJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):395-401. PubMed ID: 10794484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Critical Roles of E2F3 in Growth and Musculo-skeletal Phenotype in Mice.
    Kim HR; Rahman FU; Kim KS; Kim EK; Cho SM; Lee K; Moon OS; Seo YW; Yoon WK; Won YS; Kang H; Kim HC; Nam KH
    Int J Med Sci; 2019; 16(12):1557-1563. PubMed ID: 31839743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Long-term follow-up of neuroblastoma in children less than 18 months of age].
    Zhao J; Pan C; Xu M; Zhou M; Gao YJ; Hu WT; Tang JY
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):754-759. PubMed ID: 29050113
    [No Abstract]   [Full Text] [Related]  

  • 54. [4S neuroblastoma with bilateral adrenal tumors].
    Kerdudo C; Corradini N; Michon J; Leverger G
    Arch Pediatr; 2004 Dec; 11(12):1450-6. PubMed ID: 15596333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of Neuroblastoma: ICMR Consensus Document.
    Bansal D; Totadri S; Chinnaswamy G; Agarwala S; Vora T; Arora B; Prasad M; Kapoor G; Radhakrishnan V; Laskar S; Kaur T; Rath GK; Bakhshi S
    Indian J Pediatr; 2017 Jun; 84(6):446-455. PubMed ID: 28367616
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers.
    Cheung NK; Kushner BH; LaQuaglia MP; Kramer K; Ambros P; Ambros I; Ladanyi M; Eddy J; Bonilla MA; Gerald W
    Eur J Cancer; 1997 Oct; 33(12):2117-20. PubMed ID: 9516865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. E2F as a regulator of keratinocyte proliferation: implications for skin tumor development.
    Jones SJ; Dicker AJ; Dahler AL; Saunders NA
    J Invest Dermatol; 1997 Aug; 109(2):187-93. PubMed ID: 9242506
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Congenital stage 1 neuroblastoma evolved into stage 4s.
    Schiavetti A; Foco M; Ingrosso A; Chiriacò D; Ballesio L
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):59-60. PubMed ID: 19125091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
    Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC
    Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bilateral adrenal neuroblastoma.
    Pagès PM; Dufour C; Fasola S; Michon J; Boutard P; Gentet JC; Hartmann O
    Pediatr Blood Cancer; 2009 Feb; 52(2):196-202. PubMed ID: 18951434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.